In vitro studies have utilized human umbilical vein endothelial cells (HUVECs) to investigate angiogenic activity, human fibroblast cultures for wound migration assays, and tendon fibroblast primary cultures to examine collagen synthesis rates
GLP-1 medications may help lower several key risk factors for cardiovascular disease by improving blood pressure, blood sugar levels, and cholesterol
Critical review of exposure and effects: implications for setting regulatory health criteria for ingested copper
BPC-157 has been studied extensively in preclinical models and has demonstrated meaningful effects on tissue repair, tendon and ligament healing, muscle recovery, wound healing, angiogenesis, nitric oxide signaling, inflammation modulation, and gastrointestinal mucosal protection
GLP-1-induced pancreatitis is rare but serious
MASLD (liver disease) trial (Nature Medicine 2024): Significant liver fat reductions (up to ~81% in some arms) alongside weight loss